Finerenone, an oral medication approved for diabetes-related chronic kidney disease, may reduce urine protein levels and stabilize kidney function in adults with immunoglobulin A nephropathy (IgAN). That’s according to a one-year real-world study in China,…

Immunoglobulin A nephropathy (IgAN) shares genetic risk factors with many cardiovascular and metabolic conditions, a study found. The findings may help explain why people with IgAN are at high risk of health complications such as…